Search results for: Determining Value
Filter search results
Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
1 February 2021
…societal value of vaccines and called for the consideration of this in vaccines value assessments. Therefore, it may be surprising to learn that these broader value aspects are not typically…
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
…The Broader Value of Adult Immunisation Our review found significant evidence for the value of adult immunisation, which included examples from across the three overarching domains of vaccine value: value…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…that in my writing. We need a theoretical framework when we consider broadening frameworks of value. Otherwise, we end up with an ad hoc collection of elements of value with…
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
…conceptual idea of “value” into two components, clinical care value and health system value. Judgements as to the clinical care value of drugs and devices are based on five elements:…
A US Approach to a Framework for Payer Assessment of New Technologies
22 September 2014, 11:00pm
Payers in the US do not embrace a single, dominant method for determining the value of new technologies. With this mind, Dr Steven Pearson has convened a US policy workgroup…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…into clinical development strategies. Policy makers and payer decision-makers should expand value frameworks used in HTA to integrate broader value dimensions, fostering a comprehensive evaluation of the full value of…
5 Things You Should Do with EQ-5D Data
29 January 2016
…the characteristics of the values that are generated – for example, what the minimum value is, and how many negative values there are, and what the distribution of the values…
Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology
1 February 2021
…adding a new medicine to a currently reimbursed medicine represents value for money to the health system. In markets that utilise cost-per-QALY approaches for assessing value, a clinically effective medicine…
Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
30 March 2023
…are met. HOW CAN VALUE BE REWARDED? The system should include a value-based top-up that incentivises the development of higher-value products. The broader value of the antibiotic should be evaluated…